Skip to content

Role of a marker named Serum Autotaxin in Intrahepatic Cholestasis of Pregnancy in Indian Women

Role of Serum Autotaxin in Intrahepatic Cholestasis of Pregnancy in Indian Women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037354
Enrollment
150
Registered
2021-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O266- Liver and biliary tract disordersin pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

Research Committee All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases: Pregnant women with singleton fetus having gestational age upto 36 weeks with ICP (pruritus not associated with other dermatosis, and/or elevated serum transaminase), willing to participate in the study will be enrolled as cases. Controls: 50 Non-pregnant age matched women along with 50 pregnant women upto 36 weeks of gestation with normal LFTs not having pruritus and no history of any liver disorder, willing to participate in the study, will be enrolled as controls.

Exclusion criteria

Exclusion criteria: For cases: 1. Acute or chronic hepatitis infection (hepatitis A, B or C) 2. Other non-viral hepatitis etiologies 3. Autoimmune hepatitis 4. Extrahepatic biliary obstruction, following ultrasound examination. 5. History of liver dysfunction or any complication in the current or previous pregnancies. 6. Having pruritus due to other dermatosis. 7. Twin or multifetal gestation 8. Not willing to participate in the study For controls: 1. Pregnant patients having pre-eclampsia 2. Patients with above as cases

Design outcomes

Primary

MeasureTime frame
1. Serum Autotaxin and serum bile acid levels in both cases and controls. 2. Comparison of serum autotaxin levels with total serum bile acids in ICP. Timepoint: 1. 1st 6 months: Recruitment of patients, Sample collection and storage. 2. Next 12 months: Recruitment of patient, Sample collection, storage, Estimation of serum Autotaxin and follow up studies. 3. Last 6 months: - Analysis of data by statistical methods - Compilation of results - Preparation of manuscripts and publication of results - Preparation of project completion report

Secondary

MeasureTime frame
1.Correlation of serum Autotaxin and serum total bile acids with severity of disease. 2.Correlation of serum Autotaxin and serum total bile acids with maternal and fetal outcome Timepoint: 1. 1st 6 months: Recruitment of patients, Sample collection and storage. 2. Next 12 months: Recruitment of patient, Sample collection, storage, Estimation of serum Autotaxin and follow up studies. 3. Last 6 months: - Analysis of data by statistical methods - Compilation of results - Preparation of manuscripts and publication of results - Preparation of project completion report

Countries

India

Contacts

Public ContactSONIYA DHIMAN

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI

soniyakvs@gmail.com8126399907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026